Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia)

Biol Psychiatry. 1998 Feb 1;43(3):236-7. doi: 10.1016/S0006-3223(97)00404-6.

Abstract

Background: Impairments in both basal activity and activation of the hypothalamic-pituitary-adrenal axis (HPA) have been reported in chronic fatigue syndrome (CFS; neurasthenia). We sought to replicate these findings and examined basal activity of the HPA in a carefully selected sample of patients with CFS.

Methods: Basal activity of the HPA was assessed using salivary and urinary cortisol collection over a 24-hour period in 22 (12 male; 10 female) patients meeting criteria for CFS and appropriate controls.

Results: Salivary and urinary cortisol measures did not differ between CFS patients and controls.

Conclusions: Basal activity of the HPA was not reduced in CFS patients. Reasons for the failure to replicate previous findings are discussed.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Fatigue Syndrome, Chronic / physiopathology*
  • Female
  • Humans
  • Hydrocortisone / metabolism
  • Hydrocortisone / urine
  • Hypothalamo-Hypophyseal System / physiopathology*
  • Male
  • Pituitary-Adrenal Function Tests
  • Pituitary-Adrenal System / physiopathology*
  • Radioimmunoassay
  • Saliva / metabolism

Substances

  • Hydrocortisone